NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
December 17, 2024 — SBC Medical Group Holdings expands its footprint in Asia and launches a new B2B wellness offering. The company's strategic growth initiatives position it for success in the expanding consumer and corporate wellness sectors.
December 17, 2024 — Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) secures $1 million in equity financing, positioning itself as an emerging leader in age-reversal science. The company's leading product, Telomir-1, shows promising age-reversal and longevity benefits in preclinical studies, capitalizing on the growing global market for age-related therapies.
December 17, 2024 — Benzinga reports on Soligenix Inc.'s potential breakthrough in treating the rare cancer, CTCL, with its lead product candidate, HyBryte. The news highlights the efficacy and safety of HyBryte in clinical studies, signaling hope for individuals living with mycosis fungoides.
December 17, 2024 — ADAP Advocacy launches an interactive 340B Map highlighting the financial impact of the program on healthcare providers and the declining charity care provided to patients. The tool empowers patients to monitor the program's effects and advocates for prioritizing smaller, community-based providers.
December 17, 2024 — Creative Biolabs ADC platform enhances antibody selection, linker design, and evaluation methods for improved ADC drug development. These advancements signal progress in the biopharmaceutical industry.
December 16, 2024 — A critical malfunction in the Department of Veterans Affairs (VA) fax system threatens the safety and continuity of healthcare services for millions of veterans. The technical glitch has led to a staggering up to 50% failure rate in receiving vital requests from community care providers, potentially causing life-threatening delays in healthcare services.
December 15, 2024 — Prospect Hill Recovery introduces a new website in St. Croix to provide comprehensive support for individuals dealing with addiction and trauma. The site emphasizes personalized care, holistic approaches, and educational resources to empower clients and their families throughout the recovery process.
December 14, 2024 — Destiny Urgent Cares of Colorado offers exceptional urgent care services at their walk-in clinic in Aurora, providing accessible and affordable healthcare solutions. Patients can receive timely treatment for a variety of medical issues in a welcoming environment, establishing the clinic as a reliable option for families in need of immediate care.
December 14, 2024 — Creative Biolabs launches a new monkeypox product line, including antibodies, antigens, and detection kits, to aid researchers in studying and combating the virus. This development represents a significant step forward in the fight against infectious diseases.
December 14, 2024 — Discover the benefits of Emsculpt and Em Sculpt Neo at Elite Aesthetics - innovative body sculpting treatments designed to enhance physical appearance without surgery. Achieve your ideal body shape with cutting-edge technology and personalized care.
December 13, 2024 — Learn how to keep your pets safe during holiday meals with expert tips from Coastal Creek Animal Hospital. Protect your furry friends from potential dangers and enjoy a stress-free festive season.
December 13, 2024 — VSURGIC offers free browser-based access to live surgical observations exclusively for medical professionals and students at live.vsurgic.com. This initiative provides a unique educational opportunity for users to learn directly from world-renowned surgeons and fosters global collaboration among healthcare professionals.
December 13, 2024 — Creative Biolabs revolutionizes gut microbiota research with new LBP development technologies, including DGGE, FISH, real-time PCR, 16S rRNA sequencing, and culturomics. The company's work has significant implications for personalized medications and the future of healthcare.
December 13, 2024 — New Psychology Associate Dr. Justin Hillman joins Therapy Group of DC, focusing on anxiety therapy and improving client-therapist alliance. With a commitment to compassionate care, Dr. Hillman enhances mental health support in Washington, D.C.
December 12, 2024 — Bloom Health Centers partners with Dr. Nicki Waddell to offer individualized mental health care at Kingstowne Internal Medicine office, expanding compassionate mental health services. Services begin in January 2025, emphasizing the mind-body connection and collaborative care.
December 12, 2024 — Cogent Infotech launches CWS Health, offering customized Health IT and innovative Workforce solutions to empower organizations and address healthcare challenges. The new entity aims to drive innovation within the healthcare industry, ultimately leading to improved patient care and operational excellence.
December 11, 2024 — Exclusive Hawaii Rehab in Hakalau, HI introduces unique concierge addiction services, blending personalized care with luxury in a serene Hawaiian setting. The program caters to high-profile individuals and emphasizes individualized therapy for comprehensive treatment.
December 11, 2024 — Blue Ridge Therapeutic Wilderness introduces new initiative for adolescent care, combining outdoor immersion with creative and therapeutic indoor programming to provide a comprehensive and balanced approach to adolescent care.
December 11, 2024 — Okogen Inc. secures $3.3 million in financing to advance innovative eyecare solutions for acute infectious conjunctivitis. The funding supports the development of an AI-driven image evaluation platform and triple-combination eyedrop treatment, addressing significant gaps in managing the highly contagious condition.
December 10, 2024 — Clene (NASDAQ: CLNN) receives FDA guidance on leveraging data from its ongoing expanded access programs (“EAPs”) to support an accelerated approval application for CNM-Au8, its treatment for ALS. The FDA recommended using neurofilament light chain (“NfL”) biomarker analyses to substantiate the drug’s efficacy. Clene plans to submit additional data in mid-2025, alongside commencing the Phase 3 RESTORE-ALS trial. Clinical findings presented at an FDA meeting highlighted CNM-Au8’s significant survival benefits and benign safety profile, underscoring its potential as a transformative ALS therapy.